Harold N Keer Selected Research

Harold N Keer Research Topics

2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 06/2019
2	Neoplasms (Cancer) 11/2021 - 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024
1	Neutropenia 04/2024
1	Septic Shock (Toxic Shock Syndrome) 01/2024
1	Sepsis (Septicemia) 01/2024
1	Pneumonia (Pneumonitis) 01/2024
1	Leukemia 11/2023
1	Carcinogenesis 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Diarrhea 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Ascites 01/2018
1	Squamous Cell Carcinoma of Head and Neck 04/2013

3	guadecitabineIBA 04/2024 - 01/2018
2	MethyltransferasesIBA 01/2024 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2018
2	PlatinumIBA 11/2021 - 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024
1	Decitabine FDA Link 01/2024
1	Azacitidine (5 Azacytidine)FDA Link 01/2024
1	decitabine and cedazuridine drug combinationIBA 01/2024
1	Circulating Tumor DNAIBA 11/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2013
1	GSK 1363089IBA 04/2013